Clinical trials
Observational Inappropriate ADH Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2015 | 3 |
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 4 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Otsuka Pharmaceutical Europe Ltd | 3 |
| University Hospital, Basel, Switzerland | 2 |
| CardioKine Inc. | 1 |
| European Georges Pompidou Hospital | 1 |
| Hadassah Medical Organization | 1 |
| Hospital San Carlos, Madrid | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| King's College Hospital NHS Trust | 1 |
| Otsuka Frankfurt Research Institute GmbH | 1 |
| Otsuka Pharmaceutical Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inappropriate ADH Syndrome | 16 |
| Hyponatremia | 11 |
| Diabetes Insipidus | 6 |
| Brain Injuries, Traumatic | 1 |
| Carcinoma, Intraductal, Noninfiltrating | 1 |
| Hemorrhagic Stroke | 1 |
| Hypovolemia | 1 |
| Ischemic Attack, Transient | 1 |
| Neoplasms | 1 |
| Pituitary Diseases | 1 |
Trials
Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.